[1]
Buitron, M. et al. 2025. Doxorubicin-Induced Modulation of NF-κB, Bcl-2, and Bax Expression in Breast Cancer Cell Lines. LACCEI. 1, 12 (Apr. 2025). DOI:https://doi.org/10.18687/LACCEI2025.1.1.1649.